Tag
12 posts tagged “Less inflammation”.
An evidence-aware look at fisetin, a plant flavonoid used in intermittent senolytic protocols, and why the human data is still mostly preliminary.
What BPC-157 is, how protocols are typically structured, what to track during a cycle, and the common mistakes self-experimenters make.
A pragmatic look at teduglutide, the approved GLP-2 analog, and how a self-experimenter might track gut-related outcomes.
What Thymosin Alpha-1 is, its approval history as Zadaxin, typical protocol shapes, and how to track an immune-focused cycle.
A practical decision framework for the most common peptide stack in recovery-focused protocols. Goals, timelines, and how to track stacks cleanly.
What ARA-290 is, why it was developed for small-fiber neuropathy, and how to track pain, sensation, and inflammatory markers if you use it.
What B7-33 is, why it is studied in fibrosis and cardiac research, and why human tracking is currently very limited.
How to log KPV use across gut, skin, and inflammatory endpoints without overclaiming.
Why some users choose a pre-mixed BPC-157 and TB-500 blend, what you give up in flexibility, and how to track a stacked recovery protocol.
What the "Wolverine" branding actually is, how it differs from a plain BPC-157 / TB-500 blend on paper, and how to track either honestly.
How to think about and track proprietary multi-peptide blends marketed as one product, with honest limits on attribution.
How to log LL-37 use across antimicrobial and inflammation endpoints, with honest notes on the limited human data.